Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies to Improve Transplantation Outcomes

The National Institute of Allergy and Infectious Diseases (NIAID) is interested in supporting research that applies somatic cell gene editing (SCGE) approaches in animal models or human tissues or organs excluded from clinical use to improve graft survival and outcomes for recipients of allogenic or xenogeneic solid organ or pancreatic islet transplants, or vascularized composite allografts (VCA).

This Notice of Special Interest (NOSI) replaces NOT-AI-21-080, which expires with the issuance of this Notice.

Funding Opportunity Details

Full Announcement: NOT-AI-24-085
Related Notices or Announcements: None

Program Contact: Albert J. Hwa, Ph.D.

Activities: R21 - Exploratory/Developmental Grant; R01 - Research Project Grant

NOTE: The NIDDK does not co-sponsor the NIH Exploratory Developmental Research Grant Program (Parent R21). The NIDDK will continue to accept R21 applications submitted in response to targeted NIDDK solicitations.

Key Dates

Open Date: Read full announcement

Letter of Intent Due Date: Read full announcement

Application Due Date: February 5, 2025